NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Phase 1

Completed

Conditions: HIV Infections

Interventions: Drug: Didanosine (ddI)
Drug: Efavirenz (EFV)
Drug: Emtricitabine (FTC)

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-05

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 43

Registration Number: NCT00016718

Locations: 🇵🇷
Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS, San Juan, Puerto Rico
🇺🇸
Chicago Children's CRS, Chicago, Illinois, United States
🇺🇸
Children's Hosp. of Boston NICHD CRS, Boston, Massachusetts, United States

and more 15 locations

A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

Phase 3

Completed

Conditions: HIV Infections
Pneumonia, Pneumocystis Carinii

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 600

Registration Number: NCT00000991

Locations: 🇺🇸
Chicago Children's CRS, Chicago, Illinois, United States
🇺🇸
Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
🇺🇸
Case CRS, Cleveland, Ohio, United States

and more 18 locations

A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 240

Registration Number: NCT00000994

Locations: 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸
UCLA CARE Ctr, Los Angeles, California, United States
🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States

and more 19 locations

A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women

Phase 3

Completed

Conditions: HIV Infections
Cervix, Dysplasia

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 158

Registration Number: NCT00000758

Locations: 🇺🇸
Usc La Nichd Crs, Los Angeles, California, United States
🇺🇸
Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston, Massachusetts, United States

and more 18 locations

A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia

Not Applicable

Completed

Conditions: HIV Infections
Pneumonia, Pneumocystis Carinii

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 20

Registration Number: NCT00001003

Locations: 🇺🇸
SUNY - Stony Brook, Stony Brook, New York, United States

A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 25

Registration Number: NCT00000956

Locations: 🇺🇸
St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States
🇺🇸
JHU AVEG, Pittsburgh, Pennsylvania, United States

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 110

Registration Number: NCT00001052

Locations: 🇺🇸
JHU AVEG, Pittsburgh, Pennsylvania, United States
🇺🇸
UW - Seattle AVEG, Seattle, Washington, United States
🇺🇸
Vanderbilt Univ. Hosp. AVEG, Nashville, Tennessee, United States

and more 2 locations

The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 400

Registration Number: NCT00000983

Locations: 🇺🇸
UCLA Med Ctr / Pediatric, Los Angeles, California, United States
🇺🇸
Children's Hosp of Los Angeles/UCLA Med Ctr, Los Angeles, California, United States
🇺🇸
Cedars Sinai / UCLA Med Ctr, Los Angeles, California, United States

and more 48 locations

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

Phase 3

Completed

Conditions: HIV Infections
AIDS Dementia Complex

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 315

Registration Number: NCT00000702

Locations: 🇺🇸
Louisiana State Univ Med Ctr / Tulane Med School, New Orleans, Louisiana, United States
🇺🇸
Charity Hosp / Tulane Univ Med School, New Orleans, Louisiana, United States
🇺🇸
Julio Arroyo, West Columbia, South Carolina, United States

and more 18 locations

A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 13

Registration Number: NCT00000631

Locations: 🇺🇸
Children's Hospital & Medical Center / Seattle ACTU, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy